Search results for: hip OA

ARHP News: A Year of Achievements

Pamela J. Degotardi, PhD | October 1, 2009

What an incredible journey this past year has been for the ARHP. We have made amazing progress in education, collaboration, and chartering the ARHP’s future.

Eric Bloodaxe and the Etiology of Paget’s Disease

David S. Pisetsky, MD, PhD | October 1, 2009

The Vikings were in need of a few good rheumatologists

A New Beginning

Sherine Gabriel, MD | October 1, 2009

The growth of Arthritis Care & Research into an independent journal

Reflections on a Diamond Celebration

Gretchen Henkel | October 1, 2009

Two former presidents discuss the ACR’s 75 years of progress

Turn Down the Pain Volume

Daniel J. Clauw, MD | October 1, 2009

Fibromyalgia’s evolution from discrete entity to prototypical central pain syndrome

For many years, the ACR board of directors and Government Affairs Committee have done exemplary work in keeping members abreast of legislative regulatory issues that affect all aspects of rheumatology, including patient and physician/healthcare professional issues, education, and research. Through advocacy, the ACR advances rheumatology and fosters excellence in the care of people with, or at risk for, arthritis and rheumatic and musculoskeletal diseases. One might say that advocacy is a cornerstone of this organization.

Building a Sustainable Foundation

Leslie J. Crofford, MD | September 1, 2009

A look back at my time serving the ACR and the REF

New Annual Scientific Meeting Registration and Syllabi Initiatives

Staff | September 1, 2009

Each year, the ACR solicits feedback from annual meeting attendees. This feedback isn’t just stored in a file somewhere; it is reviewed and action is taken as a part of the ACR’s commitment to providing a quality educational experience at every annual meeting.

Obama and Clinton at the AMA

Raymond Scalettar, MD, DSc | September 1, 2009

Then and now: Déjà vu all over again—toujours?

Risks and Benefits

David S. Pisetsky, MD, PhD | September 1, 2009

Physicians must find the delicate balance between treatment and side effects